JCHOR
Journal of Current Hematology & Oncology Research

The Journal of Current Hematology & Oncology Research regularly publishes internationally qualified research in hematology and oncology within the current scholarly knowledge.

ISSN: Active
eISSN: 2980-0854
Creative Commons CC BY-NC-ND 4.0 International License.
EndNote Style

Online Manuscript System

Index
Original Article
The place of initial serum sodium and globulin ratio in the prognosis estimation of patients with lung cancer
Abstract
Aims: Since lung cancer is a disease with a high mortality and morbidity rate, determining its prognosis has a very important place. Studies in the literature have shown that electrolyte disturbance and inflammation may be associated with a poor prognosis in lung cancer, however, further studies are needed on this subject. In this study, it was planned to investigate the role of the sodium and globulin ratio measured at the time of diagnosis in the prognosis prediction of patients with lung cancer diagnosis.
Methods: The study was carried out retrospectively from the patient files and hospital records of 165 patients who were followed up with the diagnosis of lung cancer between January 1, 2015 and January 1, 2021 in XXXX University (KKU) Faculty of Medicine, Department of Internal Medicine, and Medical Oncology Department. Patients with achievable sodium, albumin, and total protein values at the time of diagnosis were included in the study. The hemogram parameters of the patients included in the study were creatinine and estimated glomerular filtration rate (eGFR), alanine aminotransferase (ALT) level, albumin level, total protein level and globulin level, C-reactive protein (CRP) level, CEA, and TSH levels. In addition, the sodium/globulin ratio (SGR) and the CRP/albumin ratio (CAR) were evaluated.
Results: 87.3% of the patients were male, and 12.7% were female. The mean age at presentation was 62.5 ± 9.1 years. Adenocancer accounts for 46.1% of cancers with 76 patients, squamous cell carcinoma for 41.8% with 69 patients, and small cell carcinoma for 12.1% with 20 patients. 11 (6.7%) of the patients were stage 1, 25 (15.2%) stage 2, 58 (35.2%) stage 3, and 71 (43%) stage 4 patients. 111 (67.3%) of the patients died. The average follow-up time is 16.6 months. In the regression analyzes performed in our study, mortality and sodium/globulin ratio (SGR) and progression-free survival and sodium/globulin ratio (SGR) were found to be unrelated. There was a weak negative correlation between the sodium/globulin ratio (SGR) and the CRP/albumin ratio (CAR). In the multivariate regression analysis, the stage of the disease, diabetes, and CRP level were found to be the independent variables affecting mortality and the stage of the disease affecting progression-free survival. (p<0.001).
Conclusion: Independent prognostic factors in patients with lung cancer; stage of disease for mortality, diabetes, and CRP level were found to be stages for progression-free survival. Considering the weak relationship between sodium/globulin ratio (SGR) and CRP/albumin ratio (CAR), SGR can be used as a future biomarker to predict prognosis in cancer patients. Further studies are needed to learn more about the relationship between SGR and lung cancer.

Keywords : Lung cancer, sodium, globulin, overall survival, mortality

Download Article


1. Arem H, Loftfield E. Cancer epidemiology: a survey of modifiablerisk factors for prevention and survivorship. Am J Lifestyle Med.2018,12(3):200-210.
2. von Allmen D. Pediatric surgical oncology: a brief overview ofwhere we have been and the challenges we face. Semin Pediatr Surg.2019;28(6):150864.
3. Wei B, Yao M, Xing C, et al. The neutrophil lymphocyte ratio isassociated with breast cancer prognosis: an updated systematic reviewand meta-analysis. Onco Targets Ther. 2016;9:5567-5575.
4. Cukic V. Neutrophil/lymphocyte ratio and platelet/lymphocyte ratio inpatients with NSCLC. Materia Socio-medica. 2016;28(5):378.
5. Singh N, Baby D, Rajguru JP, et al. Inflammation and cancer. AnnalsAfrican Med. 2019;18(3):121.
6. Instituto Portugu&ecirc;s de Oncologia do Porto Francisco Gentil, EPE,Grupo de Oncologia Molecular-CI, Edif&iacute;cio Laborat&oacute;rios, 4&ordm; piso RuaDr. Ant&oacute;nio Bernardino de Almeida, Porto, 4200-072, Portugal.
7. Rosner MH, Dalkin AC. Electrolyte disorders associated with cancer.Adv Chronic Kidney Dis. 2014;21(1):7-17.
8. Verbalis JG. Euvolemic hyponatremia secondary to the syndrome ofinappropriate antidiuresis. Disord Fluid Electrol Metab. 2019;52:61-79.
9. Chen J, Zhou Y, Xu Y, Zhu HY, Shi YQ. Low pretreatment serumglobulin may predict favorable prognosis for gastric cancer patients.Tumor Biol. 2016;37(3):3905-3911.
10. Zhang L, Wang Z, Xiao J, et al. Sodium to globulin ratio as aprognostic factor for patients with advanced gastric cancer. J Cancer.2020;11(24):7320.
11. Zhang L, Wang Z, Xiao J, et al. Sodium to globulin ratio as aprognostic factor for patients with advanced gastric cancer. J Cancer.2020;11(24):7320.
12. Coussens LM, Werb Z. Inflammation and cancer. Nature.2002;420(6917):860-867.
13. Castillo JJ, Vincent M, Justice E. Diagnosis and management ofhyponatremia in cancer patients. The Oncologist. 2012;17(6):756-765.
14. Sandfeld-Paulsen B, Aggerholm-Pedersen N, Winther-Larsen A.Hyponatremia in lung cancer: incidence and prognostic value in aDanish population- based cohort study. Lung Cancer. 2021;153:42-48.
15. Guo HW, Yuan TZ, Chen JX, Zheng Y. Prognostic value of pretreatmentalbumin/globulin ratio in digestive system cancers: a meta-analysis.Plos One. 2018;13(1):e0189839.
16. Elinav E, Nowarski R, Thaiss CA, Hu B, Jin C, Flavell RA.Inflammation-induced cancer: crosstalk between tumours, immunecells and microorganisms. Nat Rev Cancer. 2013;13(11):759-771.
17. Qu X, Pang Z, Yi W, et al. High percentage of &alpha;1-globulin in serumprotein is associated with unfavorable prognosis in non-small cell lungcancer. Medi Oncol. 2014;31(10):238.
18. Yuan K, Ye J, Liu Z, et al. Complement C3 overexpression activatesJAK2/STAT3 pathway and correlates with gastric cancer progression. JExperime Clin Cancer Res. 2020;39:1-15.
19. Oki S, Toiyama Y, Okugawa Y, et al. Clinical burden of preoperativealbumin-globulin ratio in esophageal cancer patients. Am J Surg.2017;214(5):891-898.
20. Byrd DR, Carducci MA, Compton CC, Fritz AG, Greene F. AJCC cancerstaging manual. Amin MB, Edge SB, Greene FL. (Eds.). Springer:2010:7:pp. 97-100.
21. Mustafa M, Jamalul Azizi A, IIIzam EL, Nazirah A, Sharifa A, AbbasSA. Lung cancer: risk factors, management, and prognosis. IOSR J DentMed Sci. 2016;15(10): 94-101.
22. Lu J, Xu BB, Xue Z, et al. Perioperative CRP: a novel inflammation-based classification in gastric cancer for recurrence and chemotherapybenefit. Cancer Med. 2021;10(1):34-44.
23. Tamagawa H, Aoyama T, Tamagawa A, et al. Influence of thepreoperative C-reactive protein-to-albumin ratio on survival andrecurrence in patients with esophageal cancer. Anticancer Res.2020;40(4):2365-2371.
24. Vujic J, Marsoner K, Wienerroither V, Mischinger HJ, Kornprat P.The predictive value of the CRP-to-albumin ratio for patients withpancreatic cancer after curative resection: a retrospective single centerstudy. In Vivo. 2019;33(6):2071-2078.
25. Miyamoto T, Fujitani M, Fukuyama H, Hatanaka S, Koizumi Y,Kawabata A. The C-reactive protein/albumin ratio is useful forpredicting short-term survival in cancer and noncancer patients. JPalliat Med. 2019;22(5):532-537.
26. Finlayson E, Fan Z, Birkmeyer JD. Outcomes in octogenariansundergoing high-risk cancer operation: a national study. J Am CollSurg. 2007;205(6):729-734.
27. Hoy H, Lynch T, Beck M. Surgical treatment of lung cancer. Crit CareNurs Clin. 2019;31(3):303-313.
28. Howington JA, Blum MG, Chang AC, Balekian AA, Murthy SC.Treatment of stage I and II non-small cell lung cancer: diagnosis andmanagement of lung cancer: American College of Chest Physiciansevidence-based clinical practice guidelines. Chest. 2013;143(5):e278S-e313S.
29. Yu WS, Lee CY, Park SY, et al. Prognostic factors for resected non-smallcell lung cancer in patients with type 2 diabetes mellitus. J Surg Oncol.2018;117(5):985-993.
30. Ikemura M, Nishikawa M, Kusamori K, Fukuoka M, Yamashita F,Hashida M. Pivotal role of oxidative stress in tumor metastasis underdiabetic conditions in mice. J Controlled Release. 2013;170(2):191-197.
31. Sona MF, Myung SK, Park K, Jargalsaikhan G. Type 1 diabetes mellitusand risk of cancer: a meta-analysis of observational studies. Japanese JClin Oncol. 2018;48(5):426-433.
32. Yang X, Liu Y, Mani H, et al. Biologic evaluation of diabetes andlocal recurrence in non-small cell lung cancer. Pathol Oncol Res.2017;23(1):73-77.
33. Singh P, Alex JM, Bast F. Insulin receptor (IR) and insulin-like growthfactor receptor 1 (IGF-1R) signaling systems: novel treatment strategiesfor cancer. Med Oncol. 2014;31(1):805.
34. Quinn BJ, Dallos M, Kitagawa H, et al. Inhibition of lung tumorigenesisby metformin is associated with decreased plasma IGF-I anddiminished receptor tyrosine kinase sign. Cancer Prevention Res.2013;6(8):801-810.
35. Dhillon SS, Groman A, Meagher A, Demmy T, Warren GW, YendamuriS. Metformin and not diabetes influences the survival of resected earlystage NSCLC patients. J Cancer Sci Ther. 2014;6(7): 217.
36. Nasralla A, Lee J, Dang J, Turner S. Elevated preoperative CEA isassociated with subclinical nodal involvement and worse survivalin stage I non-small cell lung cancer: a systematic review and meta-analysis. J Cardiothoracic Surg. 2020;15(1):1-8.
37. Grunnet M, Sorensen JB. Carcinoembryonic antigen (CEA) as tumormarker in lung cancer. Lung Cancer. 2012;76(2):138-143.
38. Kunutsor SK, Apekey TA, Van Hemelrijck M, Calori G, Perseghin G.Gamma glutamyltransferase, alanine aminotransferase and risk of cancer:systematic review and meta-analysis. Int J Cancer. 2015;136(5): 1162-1170.
Article available in :
Volume 1, Issue 4, 2023
Page : 88-95
https://doi.org/10.51271/JCHOR-0020
Article Information
Received : 14 Nov 2023
Accepted : 28 Nov 2023
Published : 30 Nov 2023
Corresponding Author :

Hatice Keleş: Department of Internal Medicine, Faculty of Medicine, Kırıkkale University, Kırıkkale, Turkiye

[email protected]
Citation : Yerli M, Aktaş H, Yalçın S. The place of initial serum sodium and globulin ratio in the prognosis estimation of patients with lung cancer. J Curr Hematol Oncol Res. 2023;1(4):88-95.

Read: 351
Download : 608
Cited: 0
_Footer